CLLS - Cellectis S.A. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Cellectis S.A.
Cellectis SA is a gene-editing company, employing its core proprietary technologies to develop products in the emerging field of immuno-oncology. Its two segment includes Therapeutics and Plants.
IPO Date: March 25, 2015
Sector: Healthcare
Industry: Biotech
Market Cap: $99.73M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.39 | 3.00%
Avg Daily Range (30 D): $0.08 | 4.37%
Avg Daily Range (90 D): $0.08 | 3.31%
Institutional Daily Volume
Avg Daily Volume: .19M
Avg Daily Volume (30 D): .17M
Avg Daily Volume (90 D): .07M
Trade Size
Avg Trade Size (Sh.): 138
Avg Trade Size (Sh.) (30 D): 240
Avg Trade Size (Sh.) (90 D): 212
Institutional Trades
Total Institutional Trades: 213
Avg Institutional Trade: $1.71M
Avg Institutional Trade (30 D): $1.38M
Avg Institutional Trade (90 D): $1.38M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.75M
Avg Closing Trade (30 D): $1.38M
Avg Closing Trade (90 D): $1.38M
Avg Closing Volume: 81.89K
 
News
Oct 15, 2026 @ 3:00 PM
Securities Fraud Investigation Into Cellectis S.A....
Source: Glancy Prongay Wolke & Rotter Llp
Oct 14, 2026 @ 8:54 PM
Securities Fraud Investigation Into Cellectis S.A....
Source: The Law Offices Of Frank R. Cruz
Sep 17, 2026 @ 6:45 PM
CLLS INVESTOR ALERT: Investigation of Cellectis S....
Source: Holzer & Holzer, Llc
Sep 16, 2026 @ 8:54 AM
CAR T-Cell Therapy for Acute Lymphoblastic Leukemi...
Source: Researchandmarkets.Com
Sep 11, 2026 @ 8:30 PM
Cellectis to Host Conference Call and Webcast on S...
Source: Na